Comment on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: Results of the GETUG-AFU V05 VESPER trial

• Jian-Jun Ye,
• Shang-Qing Ren,
• Yi-Ge Bao

Affiliations

Jian-Jun Ye

Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China

Shang-Qing Ren

Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Robotic Minimally Invasive Surgery Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, 610072, China

Yi-Ge Bao

Corresponding author.; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China